Back to search

National and Kapodistrian University of Athens

Η επίδραση της θεραπείας με αναστολείς της ιντερλευκίνης 17 και ιντερλευκίνης 23 στην αθηρωματική νόσο σε ασθενείς με μέτρια ή σοβαρή ψωρίαση κατά πλάκας

Abstract

dc:description

Introduction: To date, several reports demonstrated improved markers of subclinical atherosclerosis in patients with psoriasis treated with biologics. However, data on the antiatherogenic effect of IL-23 inhibitors are sparse. Herein, we sought to assess the impact of one-year treatment with an IL-17 or IL-23 inhibitor on arterial stiffness in patients with moderate-to-severe psoriasis. Methods: This observational cohort study included patients with moderate-to-severe psoriasis treated with either an IL-17 inhibitor or an IL-23 inhibitor or a conventional systemic agent/apremilast (control group) for 52 weeks. The primary outcome was the evaluation of changes in carotid-femoral pulse wave velocity (PWV) and augmentation index normalized to 75 beats/min (AIx75) after 24 and 52 weeks. Secondary outcomes were the comparison of change in PWV and AIx75 between the study groups and the assessment of psoriasis disease severity scores and in ankle-brachial index (ABI). Results: In total, 66 patients, 39 males/27 females with a mean [standard deviation (SD)] age of 56 (13.1) years, were included. Twenty-one received an IL-17 inhibitor, 29 an IL-23 inhibitor and 16 a conventional systemic agent or apremilast (control group). PWV and AIx75 improved in all groups at weeks 24 and 52. However, a statistically significant reduction of PWV was observed only in the IL-23 group as early as at week 24 (p<0.001). AIx75 was reduced significantly in the IL-17 group at week 24 and in both IL-17 and IL-23 groups at week 52 (p<0.001 and p=0.014, respectively). The reduction of PWV and AIx75 at week 52 did not reach the level of statistical significance in the control group and was statistically comparable between the IL-17 and IL-23 groups. Conclusion: Both IL-23 and IL-17 inhibition exhibited comparable improvement of arterial stiffness in patients with psoriasis. Further studies are needed to evaluate the long-term impact of biologics on the cardiovascular status of these patients.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsiogka, Aikaterini
  • Τσιόγκα, Αικατερίνη

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61746

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Tsiogka, Aikaterini; Τσιόγκα, Αικατερίνη. Η επίδραση της θεραπείας με αναστολείς της ιντερλευκίνης 17 και ιντερλευκίνης 23 στην αθηρωματική νόσο σε ασθενείς με μέτρια ή σοβαρή ψωρίαση κατά πλάκας. National and Kapodistrian University of Athens, 2026. http://hdl.handle.net/10442/hedi/61746